Assenagon Asset Management S.A. Global Blood Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$32.4 - $68.18 $13.7 Million - $28.7 Million	421,383 Added 249.68%	590,153 $40.2 Million
Q2 2022 Jul 27, 2022	BUY	$22.3 - $37.39 $3.76 Million - $6.31 Million	168,770 New	168,770 $5.39 Million
Q1 2020 Apr 17, 2020	SELL	$41.72 - $87.2 $1.23 Million - $2.58 Million	-29,571 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$45.7 - $81.86 $1.35 Million - $2.42 Million	29,571 New	29,571 $2.35 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.